Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

FDA declines to approve opioid painkiller

The FDA declined to approve Intellipharmaceutics International ‘s long-acting opioid painkiller in its current form.

Read More »

FDA Rejects J&J’s RA Drug Sirukumab

The U.S. FDA issued a Complete Response Letter calling for additional clinical data to evaluate the safety of Janssen’s rheumatoid arthritis drug sirukumab.

Read More »

Pfizer Spins Off Four of Its Best Drug Candidates Into a Startup With $103 Million

Pfizer launched a six-person biotech startup, SpringWorks Therapeutics, with a $103 million Series A financing. Joining Pfizer in funding the company was Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed and LifeArc, formerly known as MRC Technology.

Read More »

PureTech’s Gelesis says obesity drug achieved weight loss in study

PureTech subsidiary Gelesis is moving closer to filing for regulatory approval of its obesity treatment Gelesis100 after results of the latest study, the company said.

Read More »

Republicans revise Obamacare repeal bill amid tepid support

U.S. senators made a last-ditch effort to secure support for the latest Republican attempt to repeal former President Barack Obama’s signature healthcare law, releasing revised legislation to appeal to undecided senators.

Read More »

Roche cancer immunotherapy Tecentriq wins EU approval

Roche immunotherapy Tecentriq won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.

Read More »

Native American tribe moves to dismiss Allergan patent case

A Native American tribe holding patents for drugmaker Allergan Plc moved to dismiss a case brought by generic drug company Mylan NV challenging the patents.

Read More »

Versartis Growth Hormone Drug Fails Phase III Test

Versartis Inc. said the company’s experimental human growth hormone somavaratan failed to meet endpoints in a critical Phase III trial.

Read More »

Japan health minister to consider U.S. drug firms’ views in pricing overhaul

Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end a drastic revision of its drug-pricing system, aimed at reining in medical spending and cutting the public burden, the health minister said.

Read More »

Recent Cyberattack on Merck & Co. Could Lead to Drug Shortage

Federal lawmakers are concerned that a recent cyberattack on pharma giant Merck & Co. could lead to numerous problems. including a drug shortage.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom